BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25454860)

  • 1. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
    Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
    Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle.
    Sadat SMA; Snider M; Garg R; Brownlie R; van Drunen Littel-van den Hurk S
    Vaccine; 2017 Jun; 35(27):3466-3473. PubMed ID: 28527686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus.
    Cai D; Song Q; Duan C; Wang S; Wang J; Zhu Y
    Vaccine; 2018 Sep; 36(37):5591-5599. PubMed ID: 30077483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
    Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant E
    Wang S; Yang G; Nie J; Yang R; Du M; Su J; Wang J; Wang J; Zhu Y
    Vaccine; 2020 May; 38(22):3881-3891. PubMed ID: 32280039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
    Walz PH; Riddell KP; Newcomer BW; Neill JD; Falkenberg SM; Cortese VS; Scruggs DW; Short TH
    Vaccine; 2018 Jun; 36(26):3853-3860. PubMed ID: 29699786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
    Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
    Platt R; Coutu C; Meinert T; Roth JA
    Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.
    Liang R; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Aug; 25(32):5994-6006. PubMed ID: 17597267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring bovine viral diarrhea virus vaccine response: using a commercially available ELISA as a surrogate for serum neutralization assays.
    Gonda MG; Fang X; Perry GA; Maltecca C
    Vaccine; 2012 Oct; 30(46):6559-63. PubMed ID: 22944626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.
    Mahony D; Mody KT; Cavallaro AS; Hu Q; Mahony TJ; Qiao S; Mitter N
    PLoS One; 2015; 10(11):e0141870. PubMed ID: 26535891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-γ as immunoadjuvant in weaning piglets.
    Zhang H; Wen W; Zhao Z; Wang J; Chen H; Qian P; Li X
    Vaccine; 2018 Nov; 36(48):7353-7360. PubMed ID: 30366801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
    Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
    BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.
    Pecora A; Aguirreburualde MS; Aguirreburualde A; Leunda MR; Odeon A; Chiavenna S; Bochoeyer D; Spitteler M; Filippi JL; Dus Santos MJ; Levy SM; Wigdorovitz A
    Vet Res Commun; 2012 Sep; 36(3):157-64. PubMed ID: 22639081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.